Market Cap | 13.51M | P/E | - | EPS this Y | -73.70% | Ern Qtrly Grth | - |
Income | -14.09M | Forward P/E | 2.97 | EPS next Y | 76.60% | 50D Avg Chg | 3.00% |
Sales | 49.88M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -30.00% |
Dividend | N/A | Price/Book | 0.55 | EPS next 5Y | - | 52W High Chg | -88.00% |
Recommedations | 2.50 | Quick Ratio | 0.49 | Shares Outstanding | 2.23M | 52W Low Chg | 71.00% |
Insider Own | 35.84% | ROA | -17.18% | Shares Float | 1.59M | Beta | 1.71 |
Inst Own | 6.38% | ROE | -112.01% | Shares Shorted/Prior | 8.21K/12.50K | Price | 1.01 |
Gross Margin | 12.25% | Profit Margin | -28.25% | Avg. Volume | 58,998 | Target Price | 5.98 |
Oper. Margin | -19.58% | Earnings Date | Nov 11 | Volume | 121,119 | Change | 12.21% |
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.